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ABSTRACT
Quadruplex nucleic acids can be formed at the
ends of eukaryotic chromosomes. Their formation
and stabilisation by appropriate small molecules
can be used as a means of inhibiting the telom-
ere maintenance functions of telomerase in human
cancer cells. The crystal structures have been de-
termined for a number of complexes between these
small molecules and human telomeric DNA and RNA
quadruplexes. The detailed structural characteristics
of these complexes have been surveyed here and
the variations in conformation for the TTA and UUA
loops have been explored. Loop conformations have
been classified in terms of a number of discrete types
and their distribution among the crystal structures.
Sugar conformation and backbone angles have also
been examined and trends highlighted. One particu-
lar loop class has been found to be most prevalent.
Implications for in particular, rational drug design,
are discussed.
BACKGROUND––QUADRUPLEX FORM AND FUNC-
TION
Sequences containing short repetitive G-tracts occur in a
number of genomic contexts. They are often able to form
higher-order structures, termed quadruplexes (1–3), espe-
cially under the influence of appropriate small molecules,
proteins or negative supercoiling (4). Historically, the first
such sequence category to be so characterised has been in
eukaryotic telomeres, which comprise tandem repeats of
a G-tract-containing DNA sequence together with associ-
ated telomeric proteins. The hexanucleotide repeat in hu-
man telomeric DNA is 5′-TTAGGG (5). Almost all of a
telomeric DNA sequence (length varies from∼5 to∼10 kb)
is in duplex form, with the exception of the ∼150–200 nu-
cleotides at the 3′-terminus which are single-stranded (6).
This single-strandedDNA (the ‘overhang’) can be folded to
form either bimolecular (two-repeat) or unimolecular (four-
repeat) quadruplexes, once the associated single-stranded
binding proteins (principally several copies of hPOT1), have
been competed away (7,8). The concept that quadruplex-
binding small molecules can stabilise telomeric quadru-
plexes (9), has been widely used to discover small molecules
with potential anti-cancer activity via inhibition of the ac-
tion of the telomerase enzyme complex (10–14). Telomerase
is a key hallmark of cancer and is highly over-expressed in
many cancer cell types whereas it is only expressed at low
levels in normal somatic cells, suggesting that it is a plausi-
ble anti-cancer target (15,16). The reverse transcriptase ac-
tion of telomerase catalyses the synthesis of 5′-TTAGGG
repeats onto the overhang, to counteract the loss of re-
peats during replication. This overhang is required to be in
a single-stranded form to hybridise with the RNA domain
of the telomerase complex and for the catalytic cycle to pro-
ceed. Small-molecule induction of the overhang into a four-
stranded quadruplex structure, which can be augmented by
a quadruplex-binding smallmolecule (9), results in the over-
hang becoming inaccessible to the telomerase RNA tem-
plate, thus effectively inhibiting telomerase catalytic func-
tion (17).
SMALL MOLECULE BINDING TO QUADRUPLEX DNA
AND RNA
The demonstration of this concept, that telomerase inhibi-
tion can be achieved via quadruplex stabilisation with an-
thraquinone derivatives (9,18) and subsequently with many
other small molecules (10–13) has led to the widespread de-
velopment of this approach to selectively targeting human
cancers. Information on the large and structurally diverse
superfamily of quadruplex-binding small molecules is avail-
able from the G4LDB database www.g4ldb.org (19).
Several compounds including the acridine derivatives
BRACO-19 (20), RHPS4 (21), the cyclic natural prod-
uct telomestatin (22) and its analogues, and some tetra-
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substituted naphthalene diimide (ND) derivatives (23), have
been shown to selectively affect telomere maintenance in
cancer cells. Mechanistic studies have demonstrated that
the cellular responses to these agents, which occur con-
siderably more rapidly than would be expected on the ba-
sis of a classic telomerase inhibition and telomere attrition
model, involve the activation of a DNA damage response,
presumably by sensing the presence of a quadruplex nucleic
acid signal which is not associated with and protected by,
telomeric proteins (20,21,24–30). This response is an im-
portant factor in the rapidity and selectivity of the growth-
inhibitory action of these quadruplex-binding ligands in tu-
mour cells and tumour xenografts (19,20,24).
The frequency of occurrence of quadruplex-forming se-
quences other than at telomeres in the human genome has
been evaluated by informatics approaches (31–33). These
studies have shown that such sequences are especially preva-
lent in promoter sequences (34) and in 5′-UTRs (35–37).
Their over-representation in a number of oncogene pro-
moter sequences (33) has led to the hypothesis that pro-
moter quadruplexes can be targets for therapeutic inter-
vention using small molecules which stabilise a particular
quadruplex structure within a promoter sequence (38,39).
This in principle results in inhibition of the transcription of
that particular gene. The concept has been evaluated with
small molecules targeting in particular the c-MYC and c-
KIT promoter quadruplexes (see for example 10–13,39), al-
though the challenge remains of devising small molecules
capable of selectively targeting a particular quadruplex in
the absence of off-target effects on other quadruplexes. Im-
portantly, the concept of quadruplexes as targets in human
cancer has been validated by their direct visualisation in hu-
man cells and tissues (40–42).
Extensive structural data on native human telomeric
quadruplexes (HTQs) are now available from crystallo-
graphic and nuclear magnetic resonance (NMR) studies
(43–53), whereas there is currently structural information
available on only a small number of non-telomeric quadru-
plexes, of which the c-KIT, c-MYC and BCL-2 promoter
quadruplexes are the best-studied (54–64). Detailed NMR
structures have been determined for three small-molecule
complexes with c-MYC quadruplexes: bound to the por-
phyrin ligand TMPyP4 (PDB ID 2A5R) (65), bound to the
bis-quinolinium compound Phen-DC(3) (PDB ID 2MGN)
(66) and with a drug-like quindoline compound (PDB ID
2L7V) (67).
The available structural data on human telomeric
quadruplex (HTQ) complexes with small molecules are
dominated by results from X-ray crystallographic studies,
with 16 structures deposited to date in the PDB (68–76).
Of the few NMR studies on human telomeric quadruplex-
small molecule complexes that have been reported, only one
is of an intramolecular complex, bound to a derivative of
the drug telomestatin (PDB ID 2MB3) (77). The present
study focusses on the crystal structures and in particular,
analyses aspects of their conformational variability in order
to establish unifying trends and features. There are currently
no crystal structures available for small-molecule complexes
with promoter or 5′-UTR quadruplexes and only a very few
NMR structures (involving promoter quadruplexes), but
some of the underlying principles outlined below will also
apply to these complexes. One of the small-molecule com-
plexes in the database is with a bimolecular human telom-
eric RNA (TERRA) quadruplex (71), and this is comple-
mented by the availability of a crystal structure of the native
RNA quadruplex (78).
The overwhelming majority of quadruplex-binding small
molecules reported to date possess planar groupings and
their mode of binding predominantly involves 3′ or 5′ end-
stacking onto terminal G-quartets (Figure 1). Intercalative
binding has not been observed experimentally for these lig-
ands and is widely considered not to be consistent with bio-
physical data on quadruplex-smallmolecule complexes (11–
13). A small number of quadruplex-binding ligands, mostly
based on a polyamide motif, have been proposed to bind
in quadruplex grooves rather than on G-quartet surfaces.
There is no detailed experimental structural information on
their interaction with human telomeric bimolecular or uni-
molecular quadruplexes and so groove-binding structures
will not be considered any further here.
As a consequence of the rise of the quadruplex target-
ing concept, a large number of diverse quadruplex-binding
small molecules have been devised and evaluated. Most
of these have been discovered by biophysical screens of
compound libraries (11–13). Rather fewer studies have em-
ployed rational design and optimisation of ligands using
structural data fromX-ray crystallography and NMR stud-
ies. In silico docking methods, mostly using native quadru-
plex structures as starting-points, have been used in a few
instances to screen large compound libraries, (79–81). Ex-
perimental structures are crucial starting-points for in silico
studies so it is hoped that the analyses and correlations pre-
sented here will help provide sound starting-points for such
future studies.
THE FLEXIBILITY OF HUMAN TELOMERIC QUADRU-
PLEXES
It is now well-established that intramolecular quadruplexes
comprising four repeats of the human telomeric sequence
5′-TTAGGG, can form a variety of topological isomers in
solution, differing in the orientation of the backbone and
the nature of the loops formed by the ‘spacer’ TTA triplet
sequences (which can adopt lateral, diagonal or parallel ar-
rangements dependent on the orientation of the attached
strand). A number of these quadruplex topological isomers
have been identified by NMR methods (43–50); the paral-
lel form with all loops of the propeller type (also termed
strand-reversal) is the sole form found in the X-ray crys-
tallographic studies (52). The observation of a particular
quadruplex topological isomer in solution is dependent on
a number of factors, primarily quadruplex concentration,
the presence or otherwise of a molecular crowding environ-
ment, the nature of the counter-ion and the flanking se-
quences at the 5′ and 3′ ends (see for example 51,82–85).
There continues to be controversy as to which topological
isomer is the most biologically relevant, although it is plau-
sible that both parallel and anti-parallel ones can co-exist
in the high local concentration of cellular conditions. Small
molecule binding can induce the stabilisation of a particular
form (for example the induction of the parallel topology by
N-methylmesoporphyrin IX (86)); although there is to date
very incomplete understanding of the molecular basis for
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Figure 1. (A) View of the human telomeric quadruplex native and ligand complex crystal structures, with nucleic acids drawn in stick form and ligands
in surface representation. Metal ions (potassiums) are shown as purple spheres. Individual loops are highlighted with sticks in single colours. The colour
coding corresponds to the more detailed view of each loop type shown in Figure 2. (B) Structures of individual ligands, shown with the PDB IDs for the
structures in which they occur.
the preference for a particular topology; accessible surface
area of a terminal G-quartet has been suggested as being an
important factor (87).
This diversity in native HTQ topologies has not been
reflected in the folds observed in the crystal structures of
small-molecule complexes with HTQs. All have been found
to have a parallel topology, regardless of whether they are
bimolecular or unimolecular complexes (Table 1). They
crystallise in ten different crystallographic space groups,
strongly suggesting that crystal packing forces are not the
determinant of the single observed (parallel) topology. The
present survey has examined in particular the principal nu-
cleic acid conformational variable regions in these struc-
tures, the TTA loops. The structural cores of all quadru-
plexes comprise two ormore stackedG-quartets. In the case
of HTQ crystal structures the core comprises three stacked
G-quartets, which has been observed to be exceptionally
stable. Structural alignment of the three stacked G-quartets
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Table 1. Native DNA and RNA human telomeric quadruplexes and small-molecule complex crystal structures showing PDB codes, basic crystallographic
data and TTA/UUA loop types
PDB ID Sequence Description of structure
Resolution
(A˚)
Space
group R-free R-factor
No. of crystallo-
graphically
unique loops Loop type Ref.
1K8P d[UBrAG3UBrTAG3T] Native DNA 2.40 P312 1 0.280 0.193 2a Type-1 (52)
1KF1 d[AG3(T2AG3)3] Native DNA 2.10 P6 0.263 0.231 3 Type-1 (x3) (52)
2HRI d[TAG3T2AG3] Porphyrin TMPyP4 complex 2.09 C2221 0.257 0.208 2 Type-2 (68)
Type-3
3CE5 d[TAG3T2AG3T] Acridine complex 2.50 I4 0.213 0.184 2 Type-1 (70)
Type-7
3CCO d[TAG3T2AG3T] NDb complex 2.20 P6422 0.303 0.257 1 Type-4 (69)
3CDM d[TAG3(T2AG3)3] ND complex 2.10 P21 0.295 0.234 6 Type-1 (x4) (69)
Type-5
Type-6
3IBK r(UBrAG3U2AG3U) Native RNA 2.20 P3121 0.231 0.216 2c Type-1 (78)
3MIJ r(UAG3U2AG3U) RNA acridine complex 2.60 P23 0.248 0.236 1 Type-8 (71)
3QCR d[TAG3T2AG3T] Acridine complex. 3.20 P6222 0.378 0.346 1d NA (71)
3SC8 d[AG3(T2AG3)3] ND complex 2.30 P3121 0.288 0.260 3 Type-1 (72)
Type-10
Type-11
3T5E d[AG3(T2AG3)3] ND complex 2.10 P6 0.282 0.245 3 Type-1 (x3) (72)
3QSC d[AG3T2AG3T2] Salphen complex 2.40 C222 0.234 0.214 1 Type-9 (75)
3QSF d[AG3T2AG3T2] Salphen complex 2.40 C222 0.320 0.240 1 Type-9 (75)
3UYH d[AG3(T2AG3)3] ND complex 1.95 P3121 0.275 0.231 3 Type-1 (76)
Type-10
Type-11
4DA3 d[G3(T2AG3)3] ND complex 2.40 P3121 0.282 0.242 3 Type-1 (76)
Type-10
Type-12
4DAQ d[G3(T2AG3)3] ND complex 2.75 P3121 0.275 0.212 3 Type-1 (76)
Type-10
Type-12
3R6R d[AG3(T2AG3)3] Berberine complex 2.30 P6 0.252 0.217 3 Type-1 (x3) (73)
4G0F d[AG3(T2AG3)3] Mesoporphyrin complex 2.15 P6 0.262 0.239 3 Type-1 (x3) (74)
4FXM d[AG3(T2AG3)3] Mesoporphyrin complex 1.65 P21212 0.262 0.224 3 Type-1 (x3) (74)
Total no. of experimentally determined TTA or UUA loops: 43
Total no. of distinct TTA loop types: 12
Total no. of type-1 TTA loops occurrences: 26
Total number of crystal structures: 19
Total no. of distinct space groups: 10
Total no. of HTQ-ligand complexes: 16
a+cChain B loop not resolved in the electron density; bND, Naphthalene diimide; dLoop poorly resolved in the electron density.
of all HTQ crystal structures analysed in this work using the
native HTQ structure (PDB ID 1KF1) as a reference gives
an average r.m.s.d of just 0.86 A˚ (see Supplementary Ta-
ble S1 and Figure S1). This stability of the HTQG-quartets
has also been confirmed bymolecular dynamics simulations
(88–91). Accordingly, the geometry of the G-quartet core
has not been surveyed here.
Methodology used in the survey
Atomic coordinates for the telomeric quadruplex structures
were extracted from the Protein Data Bank (www.rcsb.org),
with geometric and conformational analyses performed us-
ing the 3DNA program (92) at www.x3dna.org and visu-
alised with the programs CHIMERA (93) at www.cgl.ucsf.
edu/chimera and PyMOL (94) at www.pymol.org. Each
loop was analysed individually and no averaging of con-
formational features was done. Disordered and poorly re-
solved loops were excluded from the analyses. Sugar puck-
ers were assigned directly from pseudorotation parameters
calculated by 3DNA from crystallographic coordinates.
STRUCTURAL ANALYSIS AND BACKBONE DIHE-
DRAL ANGLE COMPARISON OF HTQ TTA LOOPS
There are currently 19 X-ray crystal structures of na-
tive and small-molecule-complexed human telomeric DNA
and RNA G-quadruplexes available in the Protein Data
Bank. All of these contain d(TTA) (or r(UUA)) propeller
loops (Figure 1a, Table 1). This data set comprises 17
DNA and two RNA (i.e. TERRA/telRNA) structures.
The structures of individual ligands are shown in Fig-
ure 1b. These bimolecular and unimolecular quadruplex
native and ligand-bound structures represent a total of 43
crystallographically-determined propeller-type loops (this
number excludes three poorly-resolved loops: see Table 1).
The range of resolution in these analyses is 1.65–3.2 A˚, with
an average of 2.30 A˚. The loops have been categorised into
12 distinct groups (termed type-1, type-2. . . etc) on the ba-
sis of their overall three-dimensional shape (see Table 2 and
Figure 2a, b).
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Figure 2. (A) Views of the various TTA loop types (coloured as in Figure 1), grouped into 12 distinct categories. (B) (i) The two sub-types of type-1 loops.
Sub-type 1 (left) is from PDB structure 1KF1, sub-type 2 (right) is from PDB structure 3T5E. The structures shown here have been structurally aligned and
are presented in the same orientation. (ii) An example of the structural diversity of non-type-1 loops: overlay of a type-4 loop (pink, from PDB structure
3CCO), a type-10 loop (green, from PDB structure 3SC8) and a type-1 loop (red, from PDB structure 1KF1). The non-type-1 loops are dramatically
different to the ‘native’ type-1 TTA loop––as well as to one another. Note the retention of base-stacking interactions in the type-10 loop arrangement,
which is a common feature of non-type-1 loops.
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Type-1 propeller loops
By far themost commonly observed loop type is the interca-
lated ‘TAT’ loop found in the native telomeric DNA struc-
tures (PDB IDs 1KF1 and 1K8P), termed type-1 loops. This
loop arrangement always involves the adenine residue -
stacking above the first thymine, with the second (central)
thymine adopting one of two similar orientations: either po-
sitioned perpendicular to the G-quartet planes or stacked
(or nearly stacked) on the external face of the adenine (Fig-
ure 2b (i)). Type-1 loops have been found to occur in 13
crystal structures to date (including both native and ligand-
complexes), with a total of 26 occurrences overall (therefore
comprising over 60% of all crystallographically-observed
TTA loops). This strongly suggests that the type-1 propeller
loop is an energetically favourable and stable arrangement,
which is independent of crystal packingmode––Table 1 also
shows that these structures occur in a variety of crystallo-
graphic space groups (five distinct space groups in total). It
is perhaps significant that, although ligand binding events
often result in significant rearrangement of the type-1 loop
geometry (described below), ten distinct quadruplex-ligand
complexes exist in which the type-1 loop is preserved. This
implies further that the type-1 loop arrangement is a struc-
turally robust motif. Comparison of the backbone and gly-
cosidic dihedral angles for the type-1 loops of each of the
13 structures which contain such a loop reveals a high de-
gree of conservation in backbone geometry (Figure 3a).
The only significant deviation can be seen for a 23-mer-
naphthalene diimide derivative complex structure (PDB ID
3CDM), which has changes in the ε and  angles for the
loop adenine residue (Figure 3a).
Backbone dihedral comparison for the structures which
contain multiple type-1 loops reveals a similar level of an-
gle conservation. For example, the native 22-mer structure
(PDB ID 1KF1) and the naphthalene diimide derivative-
complexed 22-mer (PDB ID 3T5E, with identical sequence)
both contain three type-1 loops, which display a significant
level of intramolecular correlation when comparing back-
bone dihedrals (Figure 3b, c, respectively). A similar level
of correlation in dihedral angles is also seen within the 22-
mer complexes involving mesoporphyrin (PDB ID 4FXM)
and berberine (PDB ID 3R6R) (Figure 3d, e, respectively).
Non type-1 propeller loops
Of the 43 crystallographically observed TTA (orUUA) pro-
peller loops, less than 40% (17 in total) adopt conforma-
tions other than the intercalated type-1 loop arrangement
described above. These non-type-1 loops adopt a wide va-
riety of dissimilar and diverse structures in the crystal state,
which can be divided into 11 distinct groups (type-2 to type-
12) based on the orientation of the three loop bases (Fig-
ure 2a and Tables 1 and 2). The structural diversity of the
11 non-type-1 loops indicates that TTApropeller loops pos-
sess a significant degree of structural flexibility, however,
this does not necessarily signify that the crystallographically
observed loop types are unstable. Indeed, the majority of
these non-type-1 loop arrangements share the common fea-
ture of exploiting intra-loop base -stacking interactions
(Figure 2a and b(ii) and Table 2)––a feature which would
be expected to confer a degree of stability upon these loop
structures.
Comparison of backbone and glycosidic dihedral an-
gles of the 11 non-type-1 loops reveals a broad distribu-
tion in backbone geometry for the different loop arrange-
ments (Figure 3f), which is to be expected, considering
the dramatic structural variety of non-type-1 loops (Fig-
ure 2). However, there do appear to be several favourable
groupings of torsion angles––such as a preference for anti
glycosidic bond angles, particularly for the second loop
thymine––in addition to some correlation with the type-1
backbone dihedral angle distribution. As with type-1 loops,
backbone dihedral angle comparison of equivalent loop
types between different structures reveals a high level of
similarity, as seen when comparing the type-9 loops ob-
served in the two bimolecular salphen-complexed quadru-
plexes 3QSF and 3QSC (Figure 3g).
Although type-1 loops are indeed observed in a number
of HTQ-ligand complexes (as stated above), all non-type-
1 loops occur in ligand-bound HTQ structures, thus, non-
type-1 loops are almost certainly a consequence of ligand-
binding events. If one considers the type-1 loop to represent
the ‘native’ TTA loop conformation, the observation of a
further 11 distinct loop conformations––many of which are
dramatically different to the type-1 arrangement (see for ex-
ample Figure 2b(ii))––indicates clearly that TTA propeller
loops of human telomeric G-quadruplexes possess a signif-
icant degree of structural polymorphism. This observation
would be expected to have important consequences with re-
spect to the rational design of small molecules targeted to-
wards HTQs, however, the almost paradoxical observation
of both type-1 and non-type-1 loops within a single ligand-
bound HTQ structure (e.g. PDB IDs 3CDM, 3CE5, 3SC8,
3UYH, 4DA3, 4DAQ) precludes a clear conclusion: small
molecule compounds are able to elicit both dramatic and
negligible effects on TTA loop geometry.
SUGAR PUCKER ANALYSIS AND COMPARISON OF
HTQ TTA LOOPS
Sugar pucker distribution of type-1 propeller loops
Comparison of the deoxyfuranose and furanose sugar
puckers in the nucleotides of all type-1 propeller loops re-
veals an exceptionally high degree of similarity in pucker
distribution. Of the 26 type-1 loops observed in crystal
structures, 17 (65.4%) adopt a sugar pucker distribution of
C1’-exo, C3’-endo, C2’-endo respectively for the three T-T-
A nucleotides in a loop (Table 3). Interestingly, this consen-
sus pattern of pucker arrangement––a similar pucker range
to those found in DNA duplex crystal structures––is also
observed for RNA G-quadruplex type-1 loops. Analysis of
the frequency of pucker-types for each loop residue (i.e. T, T,
A/U, U, A) reveals a high level of correspondence, with the
first thymine sugar adopting a C1’-exo pucker in 69.2% of
observed instances, the second thymine adopting aC3’-endo
pucker conformation in 100% of the observed instances and
the adenine sugar adopting a C2’-endo pucker in 88.5% of
all type-1 loops (Table 4). The high level of correlation in the
distribution of sugar pucker geometry and backbone dihe-
dral angles of type-1 loops strongly implies that the folding
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Figure 3. Plots of nucleotide conformational angles in the TTA loops. (A) Backbone and glycosidic torsion angles. These are shown for all structures
containing at least one type-1 TTA (or UUA) loop. For structures which contain more than one type-1 loop only the first TTA loop is represented. (B)
Comparison of backbone and glycosidic torsions angles. These are shown of the three type-1 propeller loops of the native human telomeric unimolecular
quadruplex (PDB ID 1KF1) (each loop coloured separately; red, green or blue). (C) Comparison of backbone and glycosidic torsions angles. These are for
the three type-1 propeller loops of a naphthalene diimide telomeric quadruplex complex (PDB ID 3T5E) (each loop coloured separately; red, green or
blue). (D) Comparison of the backbone and glycosidic torsions angles. These are for the three type-1 propeller loops of the mesoporphyrin complex with a
human telomeric quadruplex (PDB ID 4FXM) (each loop coloured separately; red, green or blue). (E) Comparison of the backbone and glycosidic torsions
angles. These are for the three type-1 propeller loops in the berberine complex with a human telomeric quadruplex (PDB ID 3R6R) (each loop coloured
separately; red, green or blue). (F) Dihedral angle plots for each of the TTA residues of each of the 12 loop types (each trace represents a distinct loop type).
The loop 1 of 1KF1 (solid black line) can be used as a common reference. Dihedral angles are derived from loops from PDB structures 1KF1 (1), 2HRI (2
and 3), 3CCO (4), 3CDM (5 and 6), 3CE5 (7), 3MIJ (8), 3QSC (9), 3SC8 (10 and 11) and 4DA3 (12). (G)Type-9 loop backbone and glycosidic dihedral angles.
These are from bimolecular human quadruplexes (PDB IDs 3QSF and 3QSC) complexed with salphen ligands. (H) Comparison of backbone and glycosidic
dihedral angles in the TTA loops of the naphthalene diimide (ND) complex structures. Type-1 TTA loops are shown as blue dashed lines. Non-type-1 loops
are shown as grey dashed lines. Structures represented are: PDB IDs 3SC8, 3T5E, 3UYH, 4DA3 and 4DAQ. (I) Comparison of TTA loop backbone and
glycosidic dihedrals of naphthalene diimide complex crystal structures, for type-1 loops only.
Table 2. Qualitative TTA/UUA loop descriptors in terms of base stacking
Loop type Stacked bases Mutually perpendicular bases Orientation of 3rd base
1 T1, A3 T2, A3 T2 close to A3
2 T1, T2 - A3 away from T1, T2
3 T2, A3 T1, A3 T1 close to A3
4 - T2, A3 T1 away from T2, A3
5 T2, A3 - T1 close to T2, A3
6 T2, A3 T1 T1 away from T2, A3
7 T2, A3 T1 close to T2
8 U2, A3 U1 U1 away from U2, A3
9 No stacking - All away from each other
10 T2, A3 - T1 away from T2, A3
11 No stacking T1, T2 A3 close to T1
12 T2, A3 - T1 away from T2, A3
of TTA triplets into the type-1 arrangement is a highly pre-
cise, non-random process.
Sugar pucker distribution of non-type-1 propeller loops
As with backbone dihedral angle distribution, the sugar
puckering of non-type-1 loops is also highly variable when
comparing all 11 non-type-1 loops (Table 5). Although
there is no common consensus pucker arrangement for the
non-type-1 loops, there is a clear shift from the ‘C1’-exo,
C3’-endo,C2’-endo’ consensus of type-1 loops to a C2’-endo
conformation for all loop residues. For example, the first
thymine of the TTA loop adopts a C2’-endo pucker in 52.9%
of all non-type-1 propeller loops, compared to 23.1% in all
type-1 loops (6/26 occurrences) (Table 6). This presumably
reflects the energetic preference for C2’-endo puckered sug-
ars in DNA, and suggests the less favourable C1’-exo and
C3’-endo of the first two residues of the type-1 loops may be
compensated for by the favourable energetics of base-base
-stacking interactions.
ANALYSIS AND CONCLUSIONS
The solution NMR evidence for type-1 loops, which to-
gether with the diversity of crystal packing modes in the
crystal structures, suggests that crystal packing forces are
not contributing to the loop types. The diversity of space
groups and resulting patterns of molecular packing in these
crystals suggests that the intermolecular packing forces are
weak and therefore different packing arrangements can
readily occur. This is consistent with the assumption that
what is observed in the crystalline state are low-energy con-
formations of these complexes. We suggest that here, the
preferred conformations of the relatively flexible loops are
always among those most observed in these crystal struc-
tures.
Although the type-1 loop is present in five distinct space
groups, many of the non-type-1 loops are observed less
frequently, and thus there is not currently sufficient data
to make any definitive statements about the relationship
between space group and loop type. It should be noted,
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Table 3. Pucker distributions for TTA/UUAs of all type-1 loops
1KF1-a 1KF1-b 1KF1-c 1K8P 3IBK 3CDM-a 3CDM-b 3CDM-c 3CDM-d 3CE5 3SC8 3UYH 3T5E-a
T C1’-exo C1’-exo C1’-exo C1’-exo C1’-exo C1’-exo C4’-exo C1’-exo C1’-exo C1’-exo C1’-exo C1’-exo C2’-endo
T C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo
A C2’-endo C2’-endo C2’-endo C2’-endo C2’-endo C2’-endo C2’-endo C2’-endo C1’-exo C2’-endo C2’-endo C2’-endo C2’-endo
3T5E-b 3T5E-c 4DA3 4DAQ 3R6R-a 3R6R-b 3R6R-c 4FXM-a 4FXM-b 4FXM-c 4G0F-a 4G0F-b 4G0F-c
T C1’-exo C2’-endo C1’-exo C1’-exo C1’-exo C1’-exo C4’-exo C2’-endo C1’-exo C1’-exo C2’-endo C2’-endo C2’-endo
T C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo C3’-endo
A C2’-endo C2’-endo C2’-endo C2’-endo C2’-endo C2’-endo C2’-endo C2’-endo C2’-endo C2’-endo C1’-exo C1’-exo C2’-endo
Yellow indicates a sugar which deviates from the consensus pucker conformation. Lower-case letters denote crystallographically unique type-1 loops within a single crystal
structure.
Table 4. Percentage of each residue in type-1 loops which adopt sugar
pucker consensus ‘C1’-exo, C3’-endo, C2’-endo’
Pucker type % Observed
T 18/26 C1’-exo 69.2%
T 26/26 C3’-endo 100.0%
A 23/26 C2’-endo 88.5%
C3’-endo pucker for the second loop thymine is 100% conserved.
however, that the relationship between space group and
(loop) conformation is not necessarily a one way process––a
particular space group may affect the loop geometry, but
equally, a loop type can influence the space group into
which the molecule/DNA/RNA packs, i.e. loop-type may
define the crystal packing, rather than the packing defining
the loop-type.
Although there is no direct evidence that non-type-1
loops are produced by ligand binding, it is clear that ligand
binding is involved in some way in the formation of non-
type-1 loop arrangements. Since type-1 loops are also ob-
served in the native DNA and RNA structures, we suggest
that some ligands simply do not perturb this loop geometry,
whereas others do.
The overall question of the relationship of these crys-
tal structures to the structures and complexes present in
solution can only be addressed once much more exten-
sive data are obtained. However, there is certainly suffi-
cient data for some tentative conclusions to be drawn. One
important issue concerns the loops defined here––in par-
ticular, whether or not these structures are present in so-
lution. Importantly, there is indeed evidence for the exis-
tence of type-1 loops in solution. The NMR structure of
d[TAGGG(TTAGGG)]3 in crowded conditions (PDB ID
2LD8) clearly shows stacked type-1 loops for all three TTA
loops of all 10 structures present in the deposited ensemble
(51). Thus, the type-1 loop––which is observed frequently
crystallographically––appears to be highly stable and is very
much present in solution. A structural alignment of the
crystal and NMR structures, 1KF1 with 2LD8, (excluding
the 5′ flanking residues) gives an average RMSD of 1.981
A˚ (see Supplementary Table S2)––this is an excellent corre-
lation between solution and solid state. The overall visual
alignment of these two structures (1KF1 and 2LD8) may
be observed by scrolling through the NMR ensemble and
crystal structures and is very close. Figure 2 and Table 2
also show it is common for the loops to have at least one
unstacked base, which is highly likely to be adopting mul-
tiple conformations in solution. The patterns of base-base
stacking seen in almost all the loop types, on the other hand,
are more likely to have significant populations in solution.
An individual crystal structure provides quasi-static in-
formation about molecular structures––information em-
bedded in temperature (B) factors in part reflects crystal
lattice dynamics. Data on an ensemble of quadruplex crys-
tal structures in which the principal variables are the bound
small molecules, can, on the other hand, provide a detailed
view of conformational trends in variable regions, i.e. the
loops. The over-riding conclusion from this survey of avail-
able crystal structures is that these HTQ-ligand complexes
have a significant degree of loop conformational variability
(albeit with certain trends of conformational preference),
which adds another layer of complexity to HTQ structures,
and which needs to be taken into account when considering
them as drug targets for in silico screening and molecular
design studies. This feature of loops is likely to be common
to all quadruplexes with loops, whether they contain single-
nucleotide or much longer loops.
One key question posed by this survey is whether a partic-
ular loop conformational class is related to the nature of the
bound ligand. The type-1 loop occurs at least once in each
of all six naphthalene diimide complexes, in the berberine
complex and in both mesoporphyrin complexes, whereas it
does not occur in the salphen, or in the other porphyrin
(TMPyP4) complex. Figure 3h, i shows that for the naph-
thalene diimide complexes, there is close correspondence
between the detailed conformations of type-1 loops at the
individual torsion angle level, but this is not the case for the
other type-1 loops, where there is definite (albeit sometimes
small) conformational variation between them. The type-1
loop also occurs in the structure of the DNA quadruplex
acridine derivative (BRACO-19) complex, but not in the
RNA one––one has to bear in mind that the acridines in
these two structures are structurally very distinct from one
another. The native RNA quadruplex shares with the two
native DNA quadruplexes the preference for type-1 loops.
The loop difference between the native and acridine-bound
RNA quadruplexes is due mainly to the presence of the
acridine, which exploits (and presumably stabilises) an ex-
tended binding surface created by the addition of loop ade-
nine residues to the 5′ G-quartet––a (re)arrangement very
much dependent on hydrogen bonds involving the C2’ hy-
droxyl groups of the ribose sugars. Overall the type-1 loop is
the dominant one in the majority of these crystal structures.
Overall we conclude that loop types and conformations
are most conserved within a closely-related group of small
molecule complexes, as in the series of ND-quadruplex
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Table 5. Sugar pucker distributions for each non-type-1 loop
2RHI
2*
2RHI
3
3CCO
4
3CDM
5
3CDM
6
3CE5
7
3MIJ
8
3QSC
9
3QSF
9
3SC8
10
3SC8
11
3UYH
10
3UYH
11
4DA3
10
4DA3
12
4DAQ
10
4DAQ
12
T C3’-
endo
C2’-
endo
C2’-
endo
C1’-
endo
C2’-
endo
C2’-
endo
C3’-
exo
C2’-
endo
C2’-
endo
C2’-
endo
C3’-
endo
C2’-
endo
O4’-
endo
C2’-
endo
C3’-
exo
C1’-
exo
C4’-
exo
T C1’-
exo
C1’-
exo
C2’-
endo
C2’-
endo
C3’-
endo
C2’-
endo
C3’-
endo
C2’-
endo
C2’-
endo
C3’-
exo
C2’-
exo
C2’-
endo
C3’-
endo
C2’-
endo
C2’-
endo
C2’-
endo
C2’-
endo
A C2’-
endo
O4’-
endo
C4’-
exo
C2’-
endo
C2’-
endo
C2’-
endo
C2’-
endo
C2’-
endo
C2’-
endo
C1’-
exo
C4’-
exo
C1’-
exo
C2’-
endo
C1’-
exo
C1’-
exo
C1’-
exo
C1’-
exo
*Numbers below PDB codes denote loop type.
Table 6. Occurrence of each pucker conformation in non-type-1 loops
C1’-endo C2’-endo C3’-endo C1’-exo C2’-exo C3’-exo C4’-exo O4’-endo
% C2’-endo for
non-type-1 loops
% C2’-endo for
type-1 loops
T 1 9 2 1 0 2 1 1 52.9% (9/17) 23.1% (6/26)
T 0 10 3 2 1 1 0 0 58.8% (10/17) 0.0% (0/26)
A 0 8 0 6 0 0 2 1 47.1% (8/17) 88.5% (23/26)
There is a pronounced shift towards C2’-endo puckering for all residues of the TTA loops for non-type-1 loops when compared to type-1 loops (highlighted in bold).
structures. In these, the differences between the structures
are in the nature of the ND end-groups––all the ND com-
pounds are tetra-substituted but with different cationic ter-
mini. There is some degree of structure conservation of
type-1 loops beyond the ND complexes, especially when the
ligands are not over-sized, as is the case for the acridine
BRACO-19 and the berberine derivative. The implications
for rational drug design of quadruplex-binding ligands are
clear: in silicomodelling based on existing crystal structures
is most reliable when modelling closely similar analogues,
but even then the variability in some loops is unpredictable
and can best be determined by further experimental struc-
tures rather than for example, molecular dynamics with re-
stricted simulation times. Taking one of the existing crys-
tal structures (Table 1) as a starting-point will therefore be
useful in providing qualitative guidance on optimising ex-
isting or related ligand hits, but extension for screening of
structurally diverse libraries and scaffolds needs to be ap-
proached with caution.
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